87 related articles for article (PubMed ID: 1853574)
1. Replication-defective missense mutations within the terminal protein and spacer/intron regions of the polymerase gene of human hepatitis B virus.
Faruqi AF; Roychoudhury S; Greenberg R; Israel J; Shih CH
Virology; 1991 Aug; 183(2):764-8. PubMed ID: 1853574
[TBL] [Abstract][Full Text] [Related]
2. A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306).
Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
J Med Virol; 2007 Jun; 79(6):676-82. PubMed ID: 17457904
[TBL] [Abstract][Full Text] [Related]
3. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of a hepatitis B virus reverse transcriptase yields temperature-sensitive virus.
Seeger C; Leber EH; Wiens LK; Hu J
Virology; 1996 Aug; 222(2):430-9. PubMed ID: 8806527
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
Melegari M; Scaglioni PP; Wands JR
Hepatology; 1998 Feb; 27(2):628-33. PubMed ID: 9462667
[TBL] [Abstract][Full Text] [Related]
6. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
Baumert TF; Rogers SA; Hasegawa K; Liang TJ
J Clin Invest; 1996 Nov; 98(10):2268-76. PubMed ID: 8941643
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.
Unchwaniwala N; Sherer NM; Loeb DD
J Virol; 2016 Oct; 90(19):8705-19. PubMed ID: 27440888
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation.
Cui X; Luckenbaugh L; Bruss V; Hu J
J Virol; 2015 Oct; 89(19):10064-72. PubMed ID: 26202253
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.
Herbers U; Amini-Bavil-Olyaee S; Mueller A; Luedde T; Trautwein C; Tacke F
J Viral Hepat; 2013 Feb; 20(2):141-8. PubMed ID: 23301549
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.
Lin X; Yuan ZH; Wu L; Ding JP; Wen YM
J Virol; 2001 Dec; 75(23):11827-33. PubMed ID: 11689664
[TBL] [Abstract][Full Text] [Related]
12. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
13. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.
Shirvani-Dastgerdi E; Winer BY; Celià-Terrassa T; Kang Y; Tabernero D; Yagmur E; Rodríguez-Frías F; Gregori J; Luedde T; Trautwein C; Ploss A; Tacke F
J Hepatol; 2017 Aug; 67(2):246-254. PubMed ID: 28392234
[TBL] [Abstract][Full Text] [Related]
14. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
Tacke F; Gehrke C; Luedde T; Heim A; Manns MP; Trautwein C
J Virol; 2004 Aug; 78(16):8524-35. PubMed ID: 15280461
[TBL] [Abstract][Full Text] [Related]
15. Complementation analysis of mutants defective in different steps of HBV reverse transcription.
Schaller H; Radziwill G
Gastroenterol Jpn; 1990 Sep; 25 Suppl 2():6-10. PubMed ID: 2227268
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.
Radziwill G; Tucker W; Schaller H
J Virol; 1990 Feb; 64(2):613-20. PubMed ID: 2153228
[TBL] [Abstract][Full Text] [Related]
17. A pregenomic RNA sequence adjacent to DR1 and complementary to epsilon influences hepatitis B virus replication efficiency.
Tang H; McLachlan A
Virology; 2002 Nov; 303(1):199-210. PubMed ID: 12482672
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis.
Märschenz S; Endres AS; Brinckmann A; Heise T; Kristiansen G; Nürnberg P; Krüger DH; Günther S; Meisel H
Gastroenterology; 2006 Sep; 131(3):765-80. PubMed ID: 16952546
[TBL] [Abstract][Full Text] [Related]
19. Mutations affecting the replication capacity of the hepatitis B virus.
Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
J Viral Hepat; 2006 Jul; 13(7):427-34. PubMed ID: 16792535
[TBL] [Abstract][Full Text] [Related]
20. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal.
Tong SP; Li JS; Vitvitski L; Trépo C
Virology; 1992 Nov; 191(1):237-45. PubMed ID: 1413504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
